Advertisement

Topics

2 catheters originally developed by Dr. Riyaz Bashir receive premarket clearance by FDA

20:00 EDT 16 May 2019 | AAAS

(Temple University Health System) The US Food and Drug Administration has granted premarket notification clearance for two catheters invented by Riyaz Bashir, MD, FACC, RVT, Director of Vascular and Endovascular Medicine at Temple University Hospital, and Nicholas Green, Director of Research & Development at Thrombolex, Inc. Thrombolex is a company founded in partnership with Temple University to develop these catheter-based clot dissolving devices. This clearance now allows Thrombolex to commercialize the catheters.

Original Article: 2 catheters originally developed by Dr. Riyaz Bashir receive premarket clearance by FDA

NEXT ARTICLE

More From BioPortfolio on "2 catheters originally developed by Dr. Riyaz Bashir receive premarket clearance by FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...